Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.23%)Nav, as on 10-02-2026

  • Previous Nav

  • Net Change on 10-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to adopt passive investment strategy. The fund will invest in stocks comprising in the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Edelweiss MSCI India Domestic & World Healthcare 45 index Fund Regular Plan - Growth -1.41 1.57 7.20 19.82 13.14 14.68
MSCI India Domestic & World Healthcare 45 Index N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Edelweiss MSCI India Domestic & World Healthcare 45 index Fund Regular Plan - Growth Oct 26, 2020 7.20 19.82 13.14 1.06 166.85

Fund Holdings as on 31-January-2026

  • Sun Pharmaceutical Industries Ltd.

  • ELI LILLY & CO

  • Apollo Hospitals Enterprise Ltd.

  • Cipla Ltd.

  • Max Healthcare Institute Ltd.

  • Divi's Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • JOHNSON & JOHNSON

  • Lupin Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Fortis Healthcare Ltd.

  • ABBVIE INC

  • Laurus Labs Ltd.

  • Aurobindo Pharma Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • NOVARTIS AG

  • MERCK & CO.INC

  • Alkem Laboratories Ltd.

  • Mankind Pharma Ltd.

  • THERMO FISHER SCIENTIFIC INC

  • IPCA Laboratories Ltd.

  • Novo Nordisk A/S

  • ABBOTT LABORATORIES

  • Biocon Ltd.

  • AMGEN INC

  • INTUITIVE SURGICAL INC

  • GILEAD SCIENCES INC

  • Zydus Lifesciences Ltd.

  • DANAHER CORP

  • MEDTRONIC PLC

  • Gland Pharma Ltd.

  • STRYKER CORP

  • Aster DM Healthcare Ltd.

  • VERTEX PHARMACEUTICALS INC

  • Narayana Hrudayalaya ltd.

  • Ajanta Pharma Ltd.

  • GlaxoSmithKline Pharmaceuticals Ltd.

  • Piramal Pharma Ltd.

  • Syngene International Ltd.

  • Global Health Ltd.

  • Regeneron Pharmaceuticals Inc

  • BECTON DICKINSON AND CO

  • IQVIA HOLDINGS INC

  • AGILENT TECHNOLOGIES INC

  • Clearing Corporation of India Ltd.

  • ILLUMINA INC

  • Accrued Interest

  • Net Receivables/(Payables)

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Business Support

View More

Fund Manager

  • Cash

  • Equity

View More

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Scheme Analysis

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a Index Funds - Other fund and belongs to Edelweiss Mutual Fund. It was launched on 26-Oct-2020 and currently has an AUM of ₹166.85 crore. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is benchmarked against MSCI India Domestic & World Healthcare 45 Index as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ended down ₹-0.05(-0.23%)yesterday to ₹20.6544.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is managed by Bhavesh Jain and Amit Vora.

Fund House Contact

Edelweiss House Off. C.S.T Road, Kalina, Mumbai - 400 098

(022) 40933400
(022) 40933401